PDL BioPharma Closes $42MM in Loans as Part of LENSAR Debt Investment
PDL BioPharma said as part of a recent acquisition of assets by a subsidiary of ALPHAEON, $42 million in loans were assumed as part of the borrowings under PDL’s prior credit agreement with LENSAR.
December 29, 2015
LENSAR | PDL BioPharma
ABF Journal